Govorkova EA - Search Results

1

Influenza antivirals and their role in pandemic preparedness.

Jones JC, Yen HL, Adams P, Armstrong K, Govorkova EA. Jones JC, et al. Among authors: govorkova ea. Antiviral Res. 2023 Feb;210:105499. doi: 10.1016/j.antiviral.2022.105499. Epub 2022 Dec 23. Antiviral Res. 2023. PMID: 36567025 Free PMC article. Review.

2

The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.

Leneva IA, Roberts N, Govorkova EA, Goloubeva OG, Webster RG. Leneva IA, et al. Among authors: govorkova ea. Antiviral Res. 2000 Nov;48(2):101-15. doi: 10.1016/s0166-3542(00)00123-6. Antiviral Res. 2000. PMID: 11114412

3

Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.

Govorkova EA, Rehg JE, Krauss S, Yen HL, Guan Y, Peiris M, Nguyen TD, Hanh TH, Puthavathana P, Long HT, Buranathai C, Lim W, Webster RG, Hoffmann E. Govorkova EA, et al. J Virol. 2005 Feb;79(4):2191-8. doi: 10.1128/JVI.79.4.2191-2198.2005. J Virol. 2005. PMID: 15681421 Free PMC article.

4

Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice.

Yen HL, Monto AS, Webster RG, Govorkova EA. Yen HL, et al. Among authors: govorkova ea. J Infect Dis. 2005 Aug 15;192(4):665-72. doi: 10.1086/432008. Epub 2005 Jul 15. J Infect Dis. 2005. PMID: 16028136

5

Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.

Yen HL, Herlocher LM, Hoffmann E, Matrosovich MN, Monto AS, Webster RG, Govorkova EA. Yen HL, et al. Among authors: govorkova ea. Antimicrob Agents Chemother. 2005 Oct;49(10):4075-84. doi: 10.1128/AAC.49.10.4075-4084.2005. Antimicrob Agents Chemother. 2005. PMID: 16189083 Free PMC article.

6

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.

Ilyushina NA, Bovin NV, Webster RG, Govorkova EA. Ilyushina NA, et al. Among authors: govorkova ea. Antiviral Res. 2006 Jul;70(3):121-31. doi: 10.1016/j.antiviral.2006.01.012. Epub 2006 Feb 21. Antiviral Res. 2006. PMID: 16516984

7

The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04.

Salomon R, Franks J, Govorkova EA, Ilyushina NA, Yen HL, Hulse-Post DJ, Humberd J, Trichet M, Rehg JE, Webby RJ, Webster RG, Hoffmann E. Salomon R, et al. Among authors: govorkova ea. J Exp Med. 2006 Mar 20;203(3):689-97. doi: 10.1084/jem.20051938. Epub 2006 Mar 13. J Exp Med. 2006. PMID: 16533883 Free PMC article.

8

Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.

Yen HL, Hoffmann E, Taylor G, Scholtissek C, Monto AS, Webster RG, Govorkova EA. Yen HL, et al. Among authors: govorkova ea. J Virol. 2006 Sep;80(17):8787-95. doi: 10.1128/JVI.00477-06. J Virol. 2006. PMID: 16912325 Free PMC article.

9

Inefficient transmission of H5N1 influenza viruses in a ferret contact model.

Yen HL, Lipatov AS, Ilyushina NA, Govorkova EA, Franks J, Yilmaz N, Douglas A, Hay A, Krauss S, Rehg JE, Hoffmann E, Webster RG. Yen HL, et al. Among authors: govorkova ea. J Virol. 2007 Jul;81(13):6890-8. doi: 10.1128/JVI.00170-07. Epub 2007 Apr 25. J Virol. 2007. PMID: 17459930 Free PMC article.

10

Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.

Ilyushina NA, Hoffmann E, Salomon R, Webster RG, Govorkova EA. Ilyushina NA, et al. Among authors: govorkova ea. Antivir Ther. 2007;12(3):363-70. Antivir Ther. 2007. PMID: 17591026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page